Rangers Pharmaceutical A/S: Financial statements 2024
CVR: 40381015
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Rangers Pharmaceutical A/S (CVR 40381015) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -90,401 and a net result of DKK 1,641,287 compared with DKK 1,244,777 the year before. Equity in the 2024 report amounted to DKK -50,758,132.
- Gross Profit
- DKK -90,401
- Profit/Loss
- DKK 1,641,287
- Equity
- DKK -50,758,132
- Total Assets
- DKK 406,348
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -90K | 1.6M | -50.8M | - |
| 2023 | - | -232K | 1.2M | -52.4M | - |
| 2022 | - | -1.1M | -53.1M | -53.6M | - |
| 2021 | - | -2.7M | -2.7M | -533K | 0 |
| 2020 | - | -302K | -4.1M | -829K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Rangers Pharmaceutical A/S has published its annual report for 2023. Gross profit came to DKK -232,315, and the net result was DKK 1,244,777.
About Rangers Pharmaceutical A/S
Rangers Pharmaceutical A/S is a Danish company of the type Aktieselskab based in København K, founded in 2019. The company is in liquidation. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Niels Løber. The company is owned by Klokken Aarhus Inc.. The company has 1 employee (2019). In 2025, the company reported a gross profit of DKK -265,330 and a net result of DKK -265,257 compared with DKK 1,641,287 the year before. Equity in the 2025 report amounted to DKK 101,092.
